Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.61
+0.69 (4.96%)
Apr 9, 2026, 3:30 PM EDT - Market open
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.85 billion as of April 9, 2026. Its market cap has increased by 15.33% in one year.
Market Cap
1.85B
Enterprise Value
1.86B
1-Year Change
15.33%
Ranking
Category
Stock Price
$14.61
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.85B, an increase of 212.34%. That is a compound annual growth rate of 11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.76B | -23.64% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 1.88B |
| Capricor Therapeutics | 1.84B |
| Pharvaris | 1.82B |
| Ocular Therapeutix | 1.82B |
| AnaptysBio | 1.79B |
| Innoviva | 1.72B |
| Palvella Therapeutics | 1.72B |
| Vericel | 1.70B |